GPEQ:AU:AU-VanEck Global Listed Private Equity ETF (AUD)

ETF | Others |

Last Closing

USD 21.51

Change

+0.25 (+1.18)%

Market Cap

N/A

Volume

829.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-24 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
VAS:AU Vanguard Australian Shares

+0.53 (+0.56%)

USD 14.72B
IVV:AU iShares Core S&P 500 AUD

+0.05 (+0.10%)

USD 7.65B
VGS:AU Vanguard MSCI International Sh..

+0.07 (+0.06%)

USD 7.36B
QUAL:AU VanEck Vectors MSCI World ex A..

-0.11 (-0.21%)

USD 5.58B
IOZ:AU Ishares Core S&P/Asx 200

+0.18 (+0.59%)

USD 5.44B
STW:AU SPDR® S&P/ASX 200 Fund

+0.38 (+0.56%)

USD 5.14B
NDQ:AU Betashares Nasdaq 100

+0.26 (+0.64%)

USD 4.86B
HNDQ:AU BetaShares NASDAQ 100 ETF - Cu..

+0.45 (+1.24%)

USD 4.86B
A200:AU BetaShares Australia 200

+0.71 (+0.56%)

USD 4.72B
VTS:AU Vanguard US Total Market Share..

+0.57 (+0.15%)

USD 3.95B

ETFs Containing GPEQ:AU

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 11.11% 85% B 76% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 11.11% 82% B 75% C
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (AUD)

Quarterly Financials (AUD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike